Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
News
Erenumab found beneficial to migraine patients with unsuccessful preventive treatment history
A phase 3b trial shows the investigational monoclonal antibody was effective out to 3 months so far.
News
Top AAN picks from Clinical Neurology News’ medical editor
Top picks include presentations on SMA, targeting and screening for tau in Alzheimer’s, and the BigBrain High Resolution 3D Digital Human Brain...
News
Gait freezing relieved by spinal cord, transcranial direct-current stimulation
Pilot studies examine two different technologies to treat freezing of gait and other aspects of gait dysfunction in Parkinson’s disease patients...
News
‘Real-world’ study finds treat-to-target benefits out to 5 years
DAS28 and HAQ scores improved in patients with early RA in daily clinical practice.
News
VIDEO: Advanced alternative payment model for RA set to undergo testing
SAN DIEGO – The RA APM helps to reduce barriers to good care by providing adequate reimbursement for cognitive services through monthly payments...
News
Gout incidence is intertwined with serum urate, but only up to a point
SAN DIEGO – An analysis’ findings “[support] a role for additional factors in the pathogenesis of gout,” according to Nicola Dalbeth, MD.
News
Legislative landscape affecting rheumatology has potential wins but many challenges
The American College of Rheumatology’s advocacy website shows members how to help.
News
New RA JAK inhibitor, monoclonal antibody trial results scheduled for ACR 2017
Studies include phase 3 results for upadacitinib, phase 1/2 results of the monoclonal antibody E6011, and phase 2 safety results for filgotinib....
News
Precision medicine’s future in rheumatic diseases outlined at ACR 2017
A 2-day premeeting course and dedicated session during the meeting will highlight some of the latest developments in precision medicine for...
News
“Great debates” at ACR 2017 address biosimilar switching, new curricular milestones
Two debates at this year’s meeting are set to offer interesting viewpoints on two unsettled issues.
News
Stopping anti-TNF drugs in PsA has high rebound risk
A preponderance of evidence suggests how difficult it is for PsA patients with low disease activity to discontinue the drugs.
News
Poverty affects lupus mortality through damage accumulation
The study accounted for many confounding factors to determine the driving force behind elevated mortality in lupus patients who are poor.
News
Plenary sessions at ANA 2017 cover wide spectrum of neurologic topics
Six plenary sessions over 3 days will cover neuronal circuits and behavior, global neurology, precision medicine, antisense oligonucleotide...
News
BRAIN Initiative update to whet appetite for main ANA meeting
A panel of experts will describe the latest ideas and efforts to develop tools to understand multiple levels of neural circuitry and brain...
News
ANA 2017 offers career development sessions at all levels
Morning sessions during Oct. 15-17 offer something for everyone for career development.